Logo image of MRE.CA

MARTINREA INTERNATIONAL INC (MRE.CA) Stock Fundamental Analysis

Canada - Toronto Stock Exchange - TSX:MRE - CA5734591046 - Common Stock

10.3 CAD
-0.04 (-0.39%)
Last: 12/24/2025, 7:00:00 PM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to MRE. MRE was compared to 5 industry peers in the Automobile Components industry. MRE has a bad profitability rating. Also its financial health evaluation is rather negative. MRE is cheap, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year MRE was profitable.
MRE had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: MRE reported negative net income in multiple years.
In the past 5 years MRE always reported a positive cash flow from operatings.
MRE.CA Yearly Net Income VS EBIT VS OCF VS FCFMRE.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M

1.2 Ratios

MRE's Return On Assets of -1.07% is on the low side compared to the rest of the industry. MRE is outperformed by 80.00% of its industry peers.
With a Return On Equity value of -2.74%, MRE is not doing good in the industry: 80.00% of the companies in the same industry are doing better.
MRE has a Return On Invested Capital (6.79%) which is comparable to the rest of the industry.
Measured over the past 3 years, the Average Return On Invested Capital for MRE is in line with the industry average of 6.17%.
Industry RankSector Rank
ROA -1.07%
ROE -2.74%
ROIC 6.79%
ROA(3y)2.05%
ROA(5y)1.27%
ROE(3y)5.93%
ROE(5y)3.71%
ROIC(3y)6.88%
ROIC(5y)5.19%
MRE.CA Yearly ROA, ROE, ROICMRE.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15

1.3 Margins

MRE has a worse Operating Margin (5.30%) than 60.00% of its industry peers.
In the last couple of years the Operating Margin of MRE has declined.
MRE has a Gross Margin of 13.27%. This is amonst the worse of the industry: MRE underperforms 80.00% of its industry peers.
In the last couple of years the Gross Margin of MRE has declined.
Industry RankSector Rank
OM 5.3%
PM (TTM) N/A
GM 13.27%
OM growth 3Y60.02%
OM growth 5Y-6.65%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y14.36%
GM growth 5Y-3.14%
MRE.CA Yearly Profit, Operating, Gross MarginsMRE.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15

2

2. Health

2.1 Basic Checks

MRE has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for MRE has been reduced compared to 1 year ago.
Compared to 5 years ago, MRE has less shares outstanding
Compared to 1 year ago, MRE has a worse debt to assets ratio.
MRE.CA Yearly Shares OutstandingMRE.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
MRE.CA Yearly Total Debt VS Total AssetsMRE.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

An Altman-Z score of 1.94 indicates that MRE is not a great score, but indicates only limited risk for bankruptcy at the moment.
The Altman-Z score of MRE (1.94) is worse than 80.00% of its industry peers.
MRE has a debt to FCF ratio of 7.63. This is a slightly negative value and a sign of low solvency as MRE would need 7.63 years to pay back of all of its debts.
The Debt to FCF ratio of MRE (7.63) is worse than 80.00% of its industry peers.
A Debt/Equity ratio of 0.70 indicates that MRE is somewhat dependend on debt financing.
MRE has a Debt to Equity ratio of 0.70. This is amonst the worse of the industry: MRE underperforms 80.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.7
Debt/FCF 7.63
Altman-Z 1.94
ROIC/WACC0.8
WACC8.46%
MRE.CA Yearly LT Debt VS Equity VS FCFMRE.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B

2.3 Liquidity

MRE has a Current Ratio of 1.21. This is a normal value and indicates that MRE is financially healthy and should not expect problems in meeting its short term obligations.
MRE has a worse Current ratio (1.21) than 60.00% of its industry peers.
A Quick Ratio of 0.79 indicates that MRE may have some problems paying its short term obligations.
MRE's Quick ratio of 0.79 is on the low side compared to the rest of the industry. MRE is outperformed by 80.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.21
Quick Ratio 0.79
MRE.CA Yearly Current Assets VS Current LiabilitesMRE.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

3

3. Growth

3.1 Past

MRE shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -21.59%.
MRE shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -12.34% yearly.
Looking at the last year, MRE shows a decrease in Revenue. The Revenue has decreased by -7.25% in the last year.
Measured over the past years, MRE shows a small growth in Revenue. The Revenue has been growing by 5.35% on average per year.
EPS 1Y (TTM)-21.59%
EPS 3Y41.11%
EPS 5Y-12.34%
EPS Q2Q%173.68%
Revenue 1Y (TTM)-7.25%
Revenue growth 3Y9.84%
Revenue growth 5Y5.35%
Sales Q2Q%-3.77%

3.2 Future

Based on estimates for the next years, MRE will show a very strong growth in Earnings Per Share. The EPS will grow by 28.69% on average per year.
MRE is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -0.78% yearly.
EPS Next Y71.19%
EPS Next 2Y39.57%
EPS Next 3Y28.69%
EPS Next 5YN/A
Revenue Next Year-3.58%
Revenue Next 2Y-0.55%
Revenue Next 3Y-0.78%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
MRE.CA Yearly Revenue VS EstimatesMRE.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B 4B 5B
MRE.CA Yearly EPS VS EstimatesMRE.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.5 1 1.5 2 2.5

9

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 7.46, the valuation of MRE can be described as very cheap.
Compared to the rest of the industry, the Price/Earnings ratio of MRE indicates a rather cheap valuation: MRE is cheaper than 100.00% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 26.57. MRE is valued rather cheaply when compared to this.
MRE is valuated cheaply with a Price/Forward Earnings ratio of 4.48.
Compared to the rest of the industry, the Price/Forward Earnings ratio of MRE indicates a rather cheap valuation: MRE is cheaper than 100.00% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 24.04. MRE is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 7.46
Fwd PE 4.48
MRE.CA Price Earnings VS Forward Price EarningsMRE.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

MRE's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. MRE is cheaper than 80.00% of the companies in the same industry.
MRE's Price/Free Cash Flow ratio is rather cheap when compared to the industry. MRE is cheaper than 100.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 4.96
EV/EBITDA 3.04
MRE.CA Per share dataMRE.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

MRE's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
MRE's earnings are expected to grow with 28.69% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.1
PEG (5Y)N/A
EPS Next 2Y39.57%
EPS Next 3Y28.69%

5

5. Dividend

5.1 Amount

MRE has a Yearly Dividend Yield of 1.93%.
Compared to an average industry Dividend Yield of 2.65, MRE has a dividend in line with its industry peers.
MRE's Dividend Yield is comparable with the S&P500 average which is at 1.88.
Industry RankSector Rank
Dividend Yield 1.93%

5.2 History

The dividend of MRE has a limited annual growth rate of 1.94%.
MRE has been paying a dividend for at least 10 years, so it has a reliable track record.
MRE has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)1.94%
Div Incr Years1
Div Non Decr Years11
MRE.CA Yearly Dividends per shareMRE.CA Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.05 0.1 0.15 0.2

5.3 Sustainability

MRE has negative earnings and hence a negative payout ratio. The dividend may be in danger.
The dividend of MRE is growing, but earnings are growing more, so the dividend growth is sustainable.
DP-34.8%
EPS Next 2Y39.57%
EPS Next 3Y28.69%
MRE.CA Yearly Income VS Free CF VS DividendMRE.CA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M

MARTINREA INTERNATIONAL INC

TSX:MRE (12/24/2025, 7:00:00 PM)

10.3

-0.04 (-0.39%)

Chartmill FA Rating
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobile Components
Earnings (Last)11-11 2025-11-11/amc
Earnings (Next)03-04 2026-03-04/amc
Inst Owners15.62%
Inst Owner ChangeN/A
Ins Owners2.07%
Ins Owner ChangeN/A
Market Cap749.74M
Revenue(TTM)4.79B
Net Income(TTM)-42.01M
Analysts80
Price Target13.01 (26.31%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.93%
Yearly Dividend0.2
Dividend Growth(5Y)1.94%
DP-34.8%
Div Incr Years1
Div Non Decr Years11
Ex-Date12-31 2025-12-31 (0.05)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)24.27%
Min EPS beat(2)11.92%
Max EPS beat(2)36.61%
EPS beat(4)3
Avg EPS beat(4)-29.03%
Min EPS beat(4)-173.21%
Max EPS beat(4)36.61%
EPS beat(8)4
Avg EPS beat(8)-23.76%
EPS beat(12)7
Avg EPS beat(12)-12%
EPS beat(16)10
Avg EPS beat(16)-99.13%
Revenue beat(2)1
Avg Revenue beat(2)-1.43%
Min Revenue beat(2)-4.74%
Max Revenue beat(2)1.88%
Revenue beat(4)1
Avg Revenue beat(4)-2.95%
Min Revenue beat(4)-6.47%
Max Revenue beat(4)1.88%
Revenue beat(8)3
Avg Revenue beat(8)-1.59%
Revenue beat(12)7
Avg Revenue beat(12)1.59%
Revenue beat(16)11
Avg Revenue beat(16)3.6%
PT rev (1m)3.24%
PT rev (3m)3.24%
EPS NQ rev (1m)-3.98%
EPS NQ rev (3m)-5.02%
EPS NY rev (1m)2.15%
EPS NY rev (3m)7.41%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.88%
Revenue NY rev (1m)-0.69%
Revenue NY rev (3m)-0.43%
Valuation
Industry RankSector Rank
PE 7.46
Fwd PE 4.48
P/S 0.16
P/FCF 4.96
P/OCF 1.77
P/B 0.49
P/tB 0.5
EV/EBITDA 3.04
EPS(TTM)1.38
EY13.4%
EPS(NY)2.3
Fwd EY22.32%
FCF(TTM)2.08
FCFY20.16%
OCF(TTM)5.8
OCFY56.35%
SpS65.74
BVpS21.1
TBVpS20.57
PEG (NY)0.1
PEG (5Y)N/A
Graham Number25.59
Profitability
Industry RankSector Rank
ROA -1.07%
ROE -2.74%
ROCE 9.42%
ROIC 6.79%
ROICexc 7.17%
ROICexgc 7.28%
OM 5.3%
PM (TTM) N/A
GM 13.27%
FCFM 3.16%
ROA(3y)2.05%
ROA(5y)1.27%
ROE(3y)5.93%
ROE(5y)3.71%
ROIC(3y)6.88%
ROIC(5y)5.19%
ROICexc(3y)7.36%
ROICexc(5y)5.55%
ROICexgc(3y)7.48%
ROICexgc(5y)5.65%
ROCE(3y)9.55%
ROCE(5y)7.21%
ROICexgc growth 3Y69.12%
ROICexgc growth 5Y-4.67%
ROICexc growth 3Y69.48%
ROICexc growth 5Y-4.48%
OM growth 3Y60.02%
OM growth 5Y-6.65%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y14.36%
GM growth 5Y-3.14%
F-Score5
Asset Turnover1.22
Health
Industry RankSector Rank
Debt/Equity 0.7
Debt/FCF 7.63
Debt/EBITDA 1.87
Cap/Depr 83.49%
Cap/Sales 5.67%
Interest Coverage 3.39
Cash Conversion 73.04%
Profit Quality N/A
Current Ratio 1.21
Quick Ratio 0.79
Altman-Z 1.94
F-Score5
WACC8.46%
ROIC/WACC0.8
Cap/Depr(3y)101.84%
Cap/Depr(5y)108.45%
Cap/Sales(3y)6.36%
Cap/Sales(5y)7.06%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-21.59%
EPS 3Y41.11%
EPS 5Y-12.34%
EPS Q2Q%173.68%
EPS Next Y71.19%
EPS Next 2Y39.57%
EPS Next 3Y28.69%
EPS Next 5YN/A
Revenue 1Y (TTM)-7.25%
Revenue growth 3Y9.84%
Revenue growth 5Y5.35%
Sales Q2Q%-3.77%
Revenue Next Year-3.58%
Revenue Next 2Y-0.55%
Revenue Next 3Y-0.78%
Revenue Next 5YN/A
EBIT growth 1Y-10.62%
EBIT growth 3Y75.76%
EBIT growth 5Y-1.65%
EBIT Next Year111.28%
EBIT Next 3Y30.07%
EBIT Next 5YN/A
FCF growth 1Y30.81%
FCF growth 3YN/A
FCF growth 5Y5.08%
OCF growth 1Y-7.56%
OCF growth 3Y34.01%
OCF growth 5Y1.54%

MARTINREA INTERNATIONAL INC / MRE.CA FAQ

Can you provide the ChartMill fundamental rating for MARTINREA INTERNATIONAL INC?

ChartMill assigns a fundamental rating of 3 / 10 to MRE.CA.


What is the valuation status for MRE stock?

ChartMill assigns a valuation rating of 9 / 10 to MARTINREA INTERNATIONAL INC (MRE.CA). This can be considered as Undervalued.


How profitable is MARTINREA INTERNATIONAL INC (MRE.CA) stock?

MARTINREA INTERNATIONAL INC (MRE.CA) has a profitability rating of 2 / 10.


Can you provide the PE and PB ratios for MRE stock?

The Price/Earnings (PE) ratio for MARTINREA INTERNATIONAL INC (MRE.CA) is 7.46 and the Price/Book (PB) ratio is 0.49.


How financially healthy is MARTINREA INTERNATIONAL INC?

The financial health rating of MARTINREA INTERNATIONAL INC (MRE.CA) is 2 / 10.